Compare HF Sinclair Corporation Common Stock (DINO) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HF Sinclair Corporation Common Stock vs Nuvation Bio Inc. Class A Common Stock — how do they compare? HF Sinclair Corporation Common Stock trades at $121.3 (market cap $21.46B), while Nuvation Bio Inc. Class A Common Stock trades at $5 (market cap $1.74B). The key difference: HF Sinclair Corporation Common Stock is far larger — about 12.3× Nuvation Bio Inc. Class A Common Stock's market cap, and HF Sinclair Corporation Common Stock pays a 1.74% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold HF Sinclair Corporation Common Stock for 0 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.
| DINO | NUVB | |
|---|---|---|
Market Cap | $21.46B | $1.74B |
Volume | 2,430,580 | 9,289,619 |
Sector | Energy | Health |
52-Week High | $121.30 | $9.54 |
52-Week Low | $45.88 | $3.41 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $22.44B | $1.33B |
Dividend Yield | 1.74% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About HF Sinclair Corporation Common Stock
HF Sinclair refines and markets petroleum products, including gasoline, diesel, and jet fuel. It also operates logistics and renewable fuels businesses.
Read more on DINO →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
